5-Diphosphomevalonic acid

From WikiMD's Medical Encyclopedia

Revision as of 21:41, 14 April 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

5-Diphosphomevalonic acid (also known as mevalonate-5-diphosphate) is a significant biochemical compound in the mevalonate pathway, which is crucial for the synthesis of isoprenoids, including cholesterol, steroids, and terpenes. This compound is an intermediate product in the pathway, derived from the phosphorylation of mevalonic acid.

Biosynthesis[edit]

5-Diphosphomevalonic acid is synthesized from mevalonic acid through a two-step phosphorylation process. The first step involves the conversion of mevalonic acid to 5-phosphomevalonic acid by mevalonate kinase (MVK). The second step is the phosphorylation of 5-phosphomevalonic acid to 5-diphosphomevalonic acid, catalyzed by phosphomevalonate kinase (PMK). This biochemical pathway is essential in all higher eukaryotes, including humans, for the production of vital biomolecules.

Function[edit]

The primary function of 5-diphosphomevalonic acid is to serve as a precursor for the synthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), which are the building blocks for the synthesis of all isoprenoids. The conversion of 5-diphosphomevalonic acid to IPP is catalyzed by the enzyme diphosphomevalonate decarboxylase. IPP can then be isomerized to DMAPP, which participates in the synthesis of various isoprenoids.

Isoprenoids play critical roles in various biological processes, including cell membrane integrity, hormones, vitamins, and energy carriers. The mevalonate pathway, and by extension, 5-diphosphomevalonic acid, is thus fundamental to cellular function and organismal health.

Clinical Significance[edit]

The mevalonate pathway, including the synthesis and utilization of 5-diphosphomevalonic acid, is a target for certain drugs, such as statins, which are used to lower cholesterol levels in individuals with hypercholesterolemia. Statins work by inhibiting HMG-CoA reductase, the enzyme that catalyzes the first step in the mevalonate pathway, thereby reducing the synthesis of mevalonate and downstream products like cholesterol.

See Also[edit]

Stub icon
   This article is a biochemistry stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.